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Abstract Caspase-11 plays a crucial role in both inflammation
and apoptosis. Caspase-11 not only activates caspase-1, that is
required for the maturation of proinflammatory cytokines such
as interleukin (IL)-1 and IL-18, but also activates caspase-3,
leading to cellular apoptosis under pathological conditions. Here,
we cloned the rat homolog of caspase-11, and investigated its
inducibility by inflammatory stimuli and signal transduction
pathways involved. Deduced amino acid sequence of rat caspase-
11 showed 88.7% similarity to mouse caspase-11, and in vitro
translation of rat caspase-11 cDNA yielded approximately a 43
kDa polypeptide, which was in agreement with predicted protein
size generated from full-length rat caspase-11 cDNA. The
expression of caspase-11 was strongly induced at both mRNA
and protein levels by inflammatory stimuli such as lipopolysac-
charide (LPS), interferon-Q, and tumor necrosis factor-K in C6
rat glial cells as well as primary astrocytes. LPS induced
activation of both p38 mitogen-activated protein kinase (MAPK)
and extracellular signal-regulated kinase (ERK) in C6 cells.
However, SB203580 (specific inhibitor of p38 kinase), but not
PD98059 (specific inhibitor of ERK kinase), inhibited LPS
induction of caspase-11, indicating that induction of caspase-11
by LPS in astrocytes was mediated through the p38 MAPK
pathway. Inflammatory induction of caspase-11 in astrocytes
may play an important role in both inflammatory responses
involving these cells and auto-regulatory apoptosis of activated
astrocytes in inflammatory sites. ß 2001 Published by Elsevier
Science B.V. on behalf of the Federation of European Biochem-
ical Societies.
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1. Introduction
Caspases play a central role in cellular apoptosis [1]. A
variety of apoptotic stimuli lead to the activation of initiator
caspases, which in turn triggers the caspase cascade and ulti-
mately results in apoptotic cell death. Among over a dozen
caspases identi¢ed so far, caspase-11 has been ¢rst character-
ized as an activator of caspase-1 in mice [2]. Caspase-11-de¢-
cient mice are resistant to endotoxic shock induced by bacte-
rial lipopolysaccharide (LPS) and fail to produce mature
interleukin-1 (IL-1) in response to LPS. Also, embryonic ¢-
broblasts from caspase-11-de¢cient mice are resistant to apo-
ptosis by ectopic expression of caspase-1, indicating that cas-
pase-11 in an upstream activator of caspase-1 [3]. The human
homolog of mouse caspase-11 has not been conclusively iden-
ti¢ed, although human caspase-4 and -5 are considered to be
good candidates [4]. It has been claimed in a recent report that
caspase-5 is the human homolog of caspase-11 based on LPS
inducibility [5]. Nevertheless, the authentic homolog of mouse
caspase-11 in any other species has not been documented.
Caspase-11 has been proposed to play an important regula-
tory role in both apoptosis and in£ammatory responses [6].
Activation of caspase-11 was crucial for the activation of cas-
pase-1 [3], however, recent works demonstrated that caspase-
11 also activated caspase-3 under pathological conditions [7].
Caspase-11 has been shown to carry out an essential function
in apoptotic death of oligodendrocytes and neuronal cells [6^
8]. Caspase-11-de¢cient mice were partly resistant to the in-
duction of experimental allergic encephalomyelitis (EAE) [6]
and showed a reduced number of apoptotic cells after middle
cerebral artery occlusion [7]. The expression of caspase-11 was
increased by ischemia and hypoxia [8,9], and this increase in
the expression was believed to lead to the activation of cas-
pase-11 [7]. Recombinant procaspase-11 has been shown to
auto-process itself in vitro, supporting that an elevated con-
centration of caspase-11 in stimulated cells may be su⁄cient
for its auto-activation. Moreover, we have previously shown
that the expression of caspase-11 is induced by in£ammatory
stimulation in microglia, and caspase-11 induction constitutes
a NO-independent apoptotic pathway [10].
Mitogen-activated protein kinase (MAPK) pathways have
been implicated in in£ammatory activation of astrocytes [11^
14]. MAPKs consist of three subgroups: p38 MAPK, extra-
cellular signal-regulated kinase (ERK), and c-Jun N-terminal
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kinase/stress-activated protein kinase (JNK/SAPK) [15]. These
kinases are activated by phosphorylation of both tyrosine and
threonine residues that is catalyzed by speci¢c upstream
MAPK kinase. Activated MAPKs phosphorylate their speci¢c
substrates on serine and/or threonine residues ultimately lead-
ing to activation of speci¢c subsets of transcription factors.
The p38 MAPK and JNK/SAPK are activated by in£amma-
tory stimuli and environmental stress, while ERK is stimu-
lated mainly by growth factors and tumor promoters. In the
central nervous system (CNS), ERK and p38 MAPK have
been shown to regulate inducible nitric oxide synthase
(iNOS) and tumor necrosis factor-K (TNFK) gene expression
in endotoxin-stimulated primary glial cultures [11]. In C6 glio-
ma cells, however, iNOS expression was mediated by p38
MAPK, but not ERK [13].
Our understanding of physiological functions of caspase-11
and its evolutionary importance could be enhanced by iden-
ti¢cation of caspase-11 homologs in other species. It is of
particular interest to identify the rat homolog of caspase-11,
and to determine how its expression is regulated. This is be-
cause rat cerebral ischemia models are frequently used to in-
vestigate CNS in£ammation and apoptosis, and up-regulation
of certain caspases including caspase-11 has been reported to
play a pathogenic role in these animal models [7,9]. Thus, the
cloning of the rat homolog of caspase-11 is the prerequisite
for studies on the role of this caspase in CNS using rat in vivo
models. Based on previous reports on the critical functions of
caspase-11 in CNS pathology [6^8] and the role of astrocytes
in CNS in£ammation [16], we hypothesized that the rat ho-
molog of caspase-11 may be expressed in astrocytes, and its
expression may be up-regulated during in£ammatory activa-
tion of astrocytes. In the current work, we cloned rat caspase-
11 cDNA and demonstrated that in£ammatory induction of
caspase-11 is mediated through the p38 subgroup of MAPK
in rat astrocytes. Cloned rat caspase-11 cDNA can be further
utilized to investigate physiological or pathological roles of
caspase-11 in CNS in£ammation and apoptosis, and to under-
stand how astrocytes participate in these processes.
2. Materials and methods
2.1. Reagents and cells
LPS was obtained from Sigma (St. Louis, MO, USA). SB203580
and PD98059 were from Calbiochem (San Diego, CA, USA). Re-
combinant mouse TNFK, which has been shown to be active on rat
C6 cells [17], and recombinant rat interferon-Q (IFNQ) were purchased
from RpD Systems (Minneapolis, MN, USA). C6 rat glial cells were
obtained from American Type Culture Collection (Manassas, VA,
USA). The cell line was maintained in Dulbecco’s modi¢ed Eagle’s
medium supplemented with 10% FBS, 2 mM glutamine, and penicil-
lin^streptomycin (Gibco-BRL, Gaithersburg, MD, USA). Rat pri-
mary astrocytes were prepared as previously described with minor
modi¢cations [18,19]. In brief, forebrains of newborn Sprague^Daw-
ley rats were chopped and dissociated by trypsinization and mechan-
ical disruption. The cells were seeded into poly-L-lysine-coated culture
£asks. After in vitro culture for 10 days, astrocytes were isolated by
shaking of the culture £asks and reseeded into multi-well plates for
assays. The purity of astrocyte cultures was greater than 90%, as
determined by glial ¢brillary acidic protein immuno£uorescence stain-
ing (data not shown).
2.2. Cloning of rat caspase-11 cDNA and sequence analysis
Total RNA isolated from C6 cells was subjected to reverse tran-
scription (RT) to obtain ¢rst strand cDNA. Degenerate oligonucleo-
tide primers based on amino acid sequences of amino- and carboxy-
terminal of mouse caspase-11 polypeptide were synthesized (Gibco-
BRL) and used for ampli¢cation of rat caspase-11 cDNA from C6 cell
cDNA by polymerase chain reaction (PCR) (annealing at 50‡C with
35 cycles repeated). The nucleotide sequences of degenerate primers
were: forward, ATG GCN GAR AAY AAR CAY CCN G; reverse,
YYA RTT NCC NGG RAA NAG RTA RAA RTA YC (where
N = A, C, G, or T; R = A or G; Y = C or T). PCR product was cloned
into pCRII vector using a TOPO TA cloning kit (Invitrogen, Gronin-
gen, The Netherlands), and sequenced with T7 primer using an auto-
mated sequencing system (ABI 377; PE Applied Biosystems, Foster
City, CA, USA). Sequence analyses were done using the GeneTool
and PepTool program (DoubleTwist, Inc., Oakland, CA, USA)
2.3. In vitro transcription and translation
Coupled in vitro transcription and translation was performed as
previously described [20]. The pCRII vector harboring rat caspase-
11 cDNA was linearized by digestion with KpnI. Linearized cDNA
was gel-puri¢ed and used as a template in the coupled transcription
and translation reaction using T7 RNA polymerase, [35S]methionine,
and TNT Coupled Reticulocyte Lysate Systems (Promega, Madison,
WI, USA). Translation products were separated by 12% SDS^PAGE.
The gel was dried and exposed to X-ray ¢lm for the analysis of
translated polypeptides.
2.4. RT-PCR
Total RNA was extracted from C6 cells or primary astrocytes by a
sequential addition of 4 M guanidinium thiocyanate, 2 M sodium
acetate, and acid phenol/chloroform. RT was carried out using Super-
script (Gibco-BRL) and oligo(dT) primer. PCR ampli¢cation using
primer sets speci¢c for each gene was carried out at 60‡C annealing
temperature for 30 cycles. Nucleotide sequences of the primers were
based on the newly cloned rat caspase-11 or published cDNA sequen-
ces of caspase-1 and D-glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (caspase-11 forward, CTT CAC AGT GCG AAA GAA
CTG; caspase-11 reverse, GAG TCC ACA TTA AGA AAT GTC
TGG AGA AGC ATT TTG; caspase-1 forward, AAG ATG GCA
CAT TTC CAG GAC; caspase-1 reverse, GGG CAC TTC AAA
GTG TTC ATC; GAPDH forward, CTG CCA CTC AGA AGA
CTG TGG; GAPDH reverse, CTT GAT GTC ATC ATA CTT
GGC). Ampli¢ed RT-PCR products were separated by 1.5% agarose
gel electrophoresis and visualized by ethidium bromide staining. The
expected size of RT-PCR products is 275 bp for caspase-11, 447 bp
for caspase-1 and 234 bp for GAPDH, respectively. The sequence of
RT-PCR product was con¢rmed by direct sequencing. After an elec-
trophoresis of PCR products on 1.5% agarose gel, the bands were
excised and puri¢ed using the Geneclean kit (BIO 101 Inc., La Jolla,
CA, USA). Puri¢ed PCR products were directly sequenced using an
automated sequencing kit (ABI 377) and PCR primers.
2.5. Western blot analysis
Cells were lysed in triple-detergent lysis bu¡er (50 mM Tris^HCl,
pH 8.0, 150 mM NaCl, 0.02% sodium azide, 0.1% SDS, 1% NP-40,
0.5% sodium deoxycholate, 1 mM phenylmethylsulfonyl £uoride).
Protein concentration in cell lysates was determined using Bio-Rad
protein assay kit. An equal amount of protein for each sample was
separated by 12% SDS^PAGE and transferred to Hybond ECL nitro-
cellulose membrane (Amersham Pharmacia Biotech, Buckingham-
shire, UK). The membrane was blocked with 5% skim milk and se-
quentially incubated with rabbit polyclonal antibodies speci¢c for
mouse/rat caspase-11 (RpD Systems), phosphorylated p38 MAPK
(New England Biolabs, Beverly, MA, USA), phosphorylated p44/
p42 MAPK (ERK 1/2) (New England Biolabs), or mouse monoclonal
antibody against L-tubulin (Sigma), and then horseradish peroxidase-
conjugated anti-rabbit or mouse antibodies (Amersham Pharmacia
Biotech) followed by ECL detection (Amersham Pharmacia Biotech).
3. Results
3.1. Cloning of rat caspase-11 cDNA
To isolate rat cDNA encoding caspase-11, total RNA iso-
lated from LPS-stimulated C6 rat glioma cells was subjected
to RT-PCR using degenerate primers speci¢c for the 5P and 3P
ends of the coding region of mouse caspase-11. Primer se-
quences were based on published amino acid sequence of
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mouse caspase-11 protein. Ampli¢ed RT-PCR products were
cloned and sequenced. Deduced amino acid sequence of rat
caspase-11 protein showed 88.7% sequence homology to
mouse caspase-11 (Fig. 1). Rat caspase-11 also showed
59.5% and 53.9% amino acid sequence similarity to human
caspases-4 and -5, respectively, which are candidates for hu-
man homolog of caspase-11. Predicted Asp residues of cleav-
age sites and pentapeptide sequence ‘QACRG’ that contain
the catalytic cysteine residues were well conserved between
mouse and rat caspase-11. In vitro transcription and trans-
lation of rat caspase-11 cDNA yielded a polypeptide of ap-
proximately 43 kDa, which was in agreement with predicted
protein size generated from full-length rat caspase-11 cDNA
(Fig. 2).
3.2. Induction of caspase-11 by in£ammatory stimuli in
astrocytes
Previous studies demonstrated that the expression of mouse
caspase-11 in thymus, lung, and spleen is induced by LPS
injection [2]. Recently, it has been also reported that cas-
pase-11 expression in brain is up-regulated following focal
ischemia [9] and EAE [6]. Thus, we next analyzed inducibility
of rat caspase-11 expression in astrocytes after treatment with
in£ammatory stimuli. LPS, IFNQ, and TNFK all induced the
expression of caspase-11 mRNA in C6 glial cells (Fig. 3A). A
similar pattern of caspase-11 induction at the protein level was
Fig. 1. Amino acid sequence alignment of rat and mouse caspase-11. Nucleotide sequence of cloned rat caspase-11 (rCasp-11) cDNA was deter-
mined and its deduced amino acid sequence was compared with mouse caspase-11 (mCasp-11). Predicted Asp (D) residues of cleavage sites and
pentapeptide sequence ‘QACRG’ that contains the catalytic cysteine residue are underlined.
Fig. 2. In vitro translation of rat caspase-11. Caspase-11 was in vi-
tro translated and analyzed by 12% SDS^PAGE, followed by auto-
radiography (lane 2). As a control, in vitro transcription and trans-
lation were also done without caspase-11 cDNA (lane 1). The arrow
indicates presumed rat caspase-11 protein of V43 kDa.
Fig. 3. Induction of caspase-11 by in£ammatory stimuli in C6 cells.
C6 cells were treated with LPS (100 ng/ml), IFNQ (100 U/ml), or
TNFK (10 ng/ml) for 24 h, and then the levels of caspase-11 mes-
sages or protein were evaluated by RT-PCR (A) or Western blot
analysis (B). Amounts of GAPDH or L-tubulin were also assessed
to con¢rm the integrity and equal loading of the samples. LPS,
IFNQ, and TNFK all induced caspase-11 expression. Results are the
representative of three independent experiments.
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con¢rmed by Western blot analysis (Fig. 3B). Induction of
caspase-11 messages by in£ammatory stimuli was also ob-
served in rat primary astrocytes (Fig. 4A). Caspase-1 messages
were also analyzed for comparison. A low level of caspase-1
was constitutively expressed in astrocytes and its expression
was induced by IFNQ, but not by LPS (Fig. 4B), suggesting
partly di¡erent regulatory mechanisms between caspase-11
and caspase-1 expressions.
3.3. LPS induction of caspase-11 through p38 MAPK
In order to determine whether in£ammatory induction of
caspase-11 expression is mediated through MAPK pathways,
we analyzed activation of two subgroups of MAPK pathways,
p38 kinase and ERK, in C6 cells stimulated with LPS. LPS
strongly induced activation of p38 MAPK as demonstrated by
the appearance of phosphorylated form of the kinase (Fig. 5).
In contrast, phosphorylated ERK protein was detected in
resting cells, and the intensity of the protein band was slightly
increased in response to LPS (Fig. 5). We next employed
speci¢c chemical inhibitors of p38 MAPK or ERK pathways.
Pretreatment of C6 cells with SB203580 (a speci¢c inhibitor of
p38 kinase) before LPS treatment dose-dependently inhibited
the induction of caspase-11 protein (Fig. 6A). However, 30
WM of PD98059 (a speci¢c inhibitor for ERK kinase, MEK)
did not a¡ect caspase-11 induction (Fig. 6B). Inability of
PD98059 to inhibit caspase-11 induction was not due to the
dose of the inhibitor used. Higher concentrations of PD98059
were also without e¡ects (data not shown). Moreover, 25 WM
of PD98059 has been previously shown to inhibit ERK path-
ways and subsequent iNOS induction in rat astrocytes [11].
These results indicated that LPS-stimulated caspase-11 induc-
tion in C6 cells was mediated through p38 MAPK pathway,
but not ERK pathway.
4. Discussion
In this work, we molecularly cloned rat caspase-11 cDNA
and presented evidence that caspase-11 is induced by in£am-
matory signals through p38 MAPK pathway in astrocytes.
Since the ¢rst cloning of mouse caspase-11, a caspase-11 ho-
molog in any other species has not been identi¢ed. Caspase-4
and -5 have been proposed as the possible human homolog of
caspase-11 [4]. Among known caspase family members, cas-
pase-4 showed the strongest sequence homology to mouse
caspase-11, however, its in£ammatory inducibility was not
observed. Recently, caspase-5 has been shown to be markedly
induced by LPS in the THP-1 human monocytic cell line [5].
Thus, in spite of relatively weak sequence homology com-
pared to caspase-4, caspase-5 may be the human homolog
of caspase-11. Here, we identi¢ed for the ¢rst time an authen-
tic homolog of caspase-11 in rat. Our work demonstrated that
amino acid sequence and inducibility of caspase-11 were well
conserved between mouse and rat. Sequence analysis showed
that rat caspase-11 has higher sequence similarity to human
caspase-4 than to caspase-5. Our current cloning of rat cas-
pase-11 and future identi¢cation of caspase-11 homologs in
other species will not only help identify the real human ho-
molog of the caspase, but also enhance our understanding of
Fig. 4. Induction of caspase-11 in primary astrocyte cultures. Rat
primary astrocytes were treated with LPS (100 ng/ml), IFNQ (100
U/ml), or TNFK (10 ng/ml) for 24 h, and then caspase-11 or cas-
pase-1 messages were analyzed by RT-PCR. While caspase-11 was
induced by LPS, IFNQ, and TNFK, caspase-1 was induced only by
IFNQ. Rat GAPDH was used as an internal control in RT-PCR.
The ampli¢ed products were not observed in RT-PCR without re-
verse transcriptase (data not shown). Results are the representative
of three independent experiments.
Fig. 5. Activation of p38 MAPK and ERK by LPS. C6 cells were
treated with LPS (100 ng/ml) for the indicated time periods, and ac-
tivation of ERK and p38 MAPK was assessed by Western blot
analysis using antibodies speci¢c for phosphorylated ERK or p38
MAPK. Anti-L-tubulin antibody was also employed to show the
equal loading of samples in each lane. Results are the representative
of four independent experiments.
Fig. 6. Induction of caspase-11 by LPS through p38 MAPK. C6
cells were pretreated with increasing concentrations of SB203580
(0.2^20 WM) or PD98059 (30 WM) for 1 h before LPS treatment for
24 h. Then, levels of caspase-11 protein were assessed by Western
blot analysis. L-Tubulin was also analyzed to show the equal load-
ing of samples in each lane. Results are the representative of three
independent experiments.
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physiological functions and evolutionary importance of this
caspase.
Previous works in our laboratory and others on the role of
caspase-11 in CNS pathology [6^8] and in£ammatory induc-
tion of the caspase-11 in microglia [10] led us to examine the
inducibility of this caspase in astrocytes and signal transduc-
tion pathways involved. Astrocytes play a central role in CNS
in£ammation. Activated astrocytes have been shown to pro-
duce a variety of in£ammatory mediators, which include re-
active oxygen species and proin£ammatory cytokines [16]. In
particular, IL-1 is secreted by human and rat astrocyte cul-
tures [21,22]. Moreover, we have previously shown that mouse
astrocytes also produce IL-18 [23]. Proforms of IL-1 and IL-
18 require protease-mediated processing in order to be se-
creted. Caspase-1 is the very protease responsible for such
processing [24], and caspase-1 in turn requires caspase-11
for its activation. Thus, the expression of caspase-11 is vital
for the production of these cytokines in astrocytes. Our cur-
rent work demonstrated that caspase-11 is strongly induced
by in£ammatory stimuli such as LPS, IFNQ, and TNFK in
astrocytes. These results suggest that the presence of an in-
£ammatory ampli¢cation mechanism in the CNS, whereby
astrocytes activated by in£ammatory stimuli may produce
yet other proin£ammatory cytokines. In£ammatory induction
of caspase-11 in astrocytes has an additional meaning besides
positive ampli¢cation of in£ammatory responses involving as-
trocytes. Caspase-11 has been proposed as an initiator caspase
that can be auto-activated when its intracellular expression is
elevated [7]. Auto-activated caspase-11 initiated caspase cas-
cade, activating caspase-1 or -3 [7]. Thus, caspase-11 induc-
tion in astrocytes may potentially result in activation of e¡ec-
tor caspases (caspase-1 or -3), leading to apoptosis of
astrocytes. We have previously shown that rat astrocytes
and microglial cells undergo auto-regulatory apoptosis upon
in£ammatory activation [19,25]. Although NO was the major
apoptotic mediator in microglia, the induction of caspase-11
by in£ammatory stimulation constituted the NO-independent
apoptotic pathway in activation-induced cell death of micro-
glia [10]. In astrocytes, in£ammatory induction of caspase-11
may well play a similar role.
Previously, induction of caspase-11 has been observed after
focal ischemia in mouse and rat middle cerebral artery occlu-
sion models as well as in the EAE model [6,7,9]. However, the
expression of caspase-11 was detected only in neurons, micro-
glia, and oligodendrocytes. To our knowledge, our results are
the ¢rst to report on the expression of caspase-11 in astro-
cytes. We demonstrated the induction of caspase-11 both in
C6 glial cells and primary astrocyte cultures. Results from C6
cells and primary astrocytes complemented each other. Exper-
imental use of primary astrocyte cultures is generally preferred
compared to established cell lines to avoid undesirable mod-
i¢cations of cellular characteristics resulting from long-term
cultures or cellular transformation. The use of primary astro-
cytes, however, raises a concern about possible contamination
of a small number of microglial cells. This may be one of the
limitations of using primary cells. Our results obtained from
homogeneous C6 cell lines complemented the results from
primary cells, supporting that astrocytes indeed express cas-
pase-11 when stimulated.
The p38 MAPK has been shown to be involved in astrocyte
gene expression [11^14]. A canonical example is iNOS gene
expression. The p38 MAPK pathway was speci¢cally involved
in TNFK/IL-1K-induced iNOS gene expression in mouse as-
trocyte cultures [12] and in LPS-induced expression of the
gene in rat astrocytes [11]. The p38 MAPK, but not p44/p42
MAPK (ERK), mediated LPS/IFNQ/TNFK-induced iNOS ex-
pression in C6 rat glioma cells [13]. However, there are reports
from other laboratories that are in contrast to these results. In
glomerular mesangial cells, activation of p38 MAPK mediated
the down-regulation of iNOS expression induced by IL-1L
[26]. Also, in C6 cells, transcriptional activation of the iNOS
gene by IFNQ was independent of Ras^MAPK pathway [27].
Thus, the role of MAPK pathways in induction of iNOS gene
expression appears to depend on cell types and stimuli inves-
tigated. Moreover, even in the same cell types, the same stim-
uli may use diverse signaling pathways for the induction of
di¡erent sets of target genes. Regulation of caspase-11 expres-
sion may well be as complex as iNOS. As presented in the
present studies, p38 MAPK mediated LPS-induced caspase-11
expression in C6 cells. However, as more studies are con-
ducted in the future, it is possible that results on the role of
p38 MAPK in caspase-11 expression may be di¡erent depend-
ing on cell types, stimuli, and species tested.
In conclusion, we have shown in this work that caspase-11
expression is strongly induced by in£ammatory signals in rat
astrocytes, and p38 MAPK pathway may be involved in these
processes. In£ammatory induction of caspase-11 in astrocytes
may play an important role in both in£ammatory responses
involving these cells and auto-regulatory apoptosis of acti-
vated astrocytes in in£ammatory sites.
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